Ranjani Raghavan
TMT
A chunk of tech has assumed growth capital stage risk in pandemic: Gaja Capital founder
The pandemic has propelled Gaja Capital's growth capital investments in technology as well as sped up the digitisation of the ......
Finance
Siguler Guff marks final close of co-investment fund for India, emerging markets
US multi-strategy private equity firm Siguler Guff & Company has marked the final close of a global emerging markets co-investment ......
Finance
SEBI allows FoFs to make direct bets, relaxes liability for investment committees
An Indian fund of funds (FoF) backing private equity or venture capital funds can invest up to 25% of corpus ......
Infrastructure
The pandemic has made ESG more pronounced: CPPIB's Su
The pandemic has highlighted the importance of environmental, social and governance (ESG) norms for investors, said a top executive of ......
TMT
ChrysCap's Shroff on how the firm's strategy has evolved since pandemic first broke out
Homegrown private equity (PE) firm ChrysCapital, operating in India for over 20 years, is currently investing out of its eighth ......
TMT
Unicorn Watch: Chargebee sets sights on new verticals, global expansion
Unlike most other India-born startups that fetched unicorn valuations this year, it took recurring billing solutions platform Chargebee a good ......
TMT
Just-born unicorn PharmEasy in talks with US investor for an even bigger valuation
Epharmacy unicorn PharmEasy is in initial discussions to add a marquee investor to its cap table which already boasts very ......
Finance
Investment banks are losing young talent to corporate sector, work-life balance
Investment banks are struggling to arrest attrition while also keeping their younger talent motivated as the community moves into the ......
Healthcare
French firm Sanofi looks to sell select non-core drugs to local pharma company
Sanofi India Ltd, local unit of the French drugmaker, is in advanced discussions to sell a non-core portfolio of over-the-counter drugs ......
Healthcare
Quadria Capital preparing to exit biotech firm
India and Southeast Asia-focused Quadria Capital is preparing to exit a biotech portfolio firm as deals in the broader pharmaceuticals ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News